US EditionPublished • loading... • Updated
Biocon Rises After Launching GLP-1 Peptide Liraglutide in the Netherlands
Mumbai, 16 December (Udaipur Kiran) — Shares of Biocon moved higher on Monday after the company announced the launch of its GLP-1 peptide, Liraglutide, in the Netherlands for diabetes and obesity management. The stock was trading at Rs. 391.30, up 1.20% from its previous close of Rs. 386.65. It opened at Rs. 387.45 and touched an intraday high of Rs. 391.40. As many as 60,966 shares were traded on the counter. The scrip has a 52-week high of Rs.…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biocon Rises After Launching GLP-1 Peptide Liraglutide in the Netherlands
Mumbai, 16 December (Udaipur Kiran) — Shares of Biocon moved higher on Monday after the company announced the launch of its GLP-1 peptide, Liraglutide, in the Netherlands for diabetes and obesity management. The stock was trading at Rs. 391.30, up 1.20% from its previous close of Rs. 386.65. It opened at Rs. 387.45 and touched an intraday high of Rs. 391.40. As many as 60,966 shares were traded on the counter. The scrip has a 52-week high of Rs.…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
